Market Size –
The whole slide imaging market size has grown rapidly in recent years. It will grow from $0.70 billion in 2023 to $0.79 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to the increasing prevalence of cancer, growing demand for whole slide imaging, increasing adoption of digital pathology, government funding and support, and economic growth.
The whole slide imaging market size is expected to see rapid growth in the next few years. It will grow to $1.25 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to the rising prevalence of chronic diseases, increasing adoption of cloud-based solutions, increasing demand for quick results, growing popularity of virtual/digital slides, and sizable research conducted with drugs. Major trends in the forecast period include integration with artificial intelligence (AI), growth in digital pathology adoption, expansion in research and development, technological innovations, and an increase in strategic partnerships.
Order your report now for swift delivery @
https://thebusinessresearchcompany.com/report/whole-slide-imaging-global-market-report
Scope Of Whole Slide Imaging Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Whole Slide Imaging Market Overview
Market Drivers –
The increasing prevalence of cancer is expected to propel the growth of the whole slide imaging market going forward. Cancer is a broad group of diseases characterized by the uncontrolled growth and spread of abnormal cells. These abnormal cells can invade and destroy normal tissue, potentially leading to serious health issues and, if not treated, death. The prevalence of cancer is due to the obesity epidemic, inherited genetic abnormalities, hepatitis B and C viruses, and human papillomavirus (HPV). Whole slide imaging (WSI) plays a significant role in cancer diagnosis and treatment by providing detailed and accessible digital representations of tissue samples, enhancing the accuracy, efficiency, and collaboration in cancer diagnosis and treatment, ultimately contributing to better patient outcomes. For instance, in May 2024, according to the American Society of Clinical Oncology, a US-based professional organization, an estimated 20 million new cancer cases were found in 2022, and expected to reach 35 million new cases globally by 2050. Therefore, the increasing prevalence of cancer is driving the growth of the whole slide imaging market.
Market Trends –
Major companies operating in the whole slide-image market are focused on developing innovative products, such as high-capacity slide scanners, to sustain their position in the market. High-capacity slide scanners are specialized devices that digitize entire microscope slides at high resolution. These scanners are designed to capture detailed digital images of tissue specimens, cytology samples, or other biological materials mounted on glass slides. For instance, in June 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, launched the VENTANA DP 600 slide scanner for digital pathology. This high-capacity slide scanner is designed to create high-resolution digital images of stained tissue samples, aiding in diagnosing diseases like cancer and enabling personalized treatment plans. The scanner provides easy use and workflow flexibility in pathology labs, allowing for efficient and streamlined diagnostic processes.
The whole slide imaging market covered in this report is segmented –
1) By Type: Hardware, Software, Services
2) By Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology
3) By End User: Academic Institute, Research, Other End User
Get an inside scoop of the whole slide imaging market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16214&type=smp
Regional Insights –
North America was the largest region in the whole slide imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole slide imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the whole slide imaging market are General Electric Company, F. Hoffmann-La Roche AG, Koninklijke Philips N.V., Olympus Corporation, Nikon Corporation, PerkinElmer Inc., Beckman Coulter Inc., Leica Biosystems GmbH, Hamamatsu Photonics KK, Huron Technologies International, Sectra AB, PathAI, Xifin Inc., OptraSCAN, Paige.AI, Indica Labs, 3DHISTECH Ltd., Visiopharm A/S, Flagship Biosciences Inc., Proscia Inc., LigoLab Information System, Aiforia Technologies plc, Inspirata Inc., Histowiz, Mikroscan Technologies Inc., Corista LLC, Glencoe Software Inc., Definiens AG
Table of Contents
1. Executive Summary
2. Whole Slide Imaging Market Characteristics
3. Whole Slide Imaging Market Trends And Strategies
4. Whole Slide Imaging Market – Macro Economic Scenario
5. Global Whole Slide Imaging Market Size and Growth
.
.
.
31. Whole Slide Imaging Market Other Major And Innovative Companies
32. Global Whole Slide Imaging Market Competitive Benchmarking
33. Global Whole Slide Imaging Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Whole Slide Imaging Market
35. Whole Slide Imaging Market Future Outlook and Potential Analysis
36.Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model